Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD
Open accessAbstract
OBJECTIVE: Pharmacological and behavioral therapies have limited impact on the distinct neurocognitive impairments associated with ADHD, and existing cognitive training programs have shown limited efficacy. This proof-of-concept study assessed treatment acceptability and explored outcomes for a novel digital treatment targeting cognitive processes implicated in ADHD. METHOD: Participants included 40 children with ADHD and 40 children without ADHD. Following psychiatric screening, ADHD ratings, and baseline neuropsychological measures, participants completed 28-days of at-home treatment. Neuropsychological assessment was repeated at end-of-study along with treatment satisfaction measures. RESULTS: Eighty-four percent of treatment sessions were completed and ratings showed strong intervention appeal. Significant improvements were observed on a computerized attention task for the ADHD group and a highly impaired ADHD High Severity subgroup. There was no change for the non-ADHD group. Spatial working memory also improved for the ADHD group and the ADHD High Severity subgroup. CONCLUSION: Findings provide preliminary support that this treatment may improve attention, working memory, and inhibition in children with ADHD. Future research requires larger-scale randomized controlled trials that also evaluate treatment impact on functional impairments. TRIAL REGISTRATION: ClinicalTrials.gov NCT01943539.
AI snapshot
Written from the paper’s full text.
TL;DR
This open-label proof-of-concept study tested an at-home digital intervention (Project: EVO) in 40 children with ADHD and 40 without ADHD over 28 days, finding high compliance and acceptability. Preliminary cognitive improvements were observed in ADHD, especially a high-severity subgroup, but the design cannot establish efficacy.
Key findings
- Compliance and acceptability were high: 84% of prescribed in-home sessions were completed overall (≈10.9 hours per child); ADHD completed 81%, ADHD High Severity 86%, and non-ADHD 87%. There were no ADHD dropouts, 9 adverse events reported, and none judged related to EVO; child enjoyment averaged 6.9/10.
- Attention improved on the TOVA Attention Performance Index for the ADHD group (N=40, t=2.21, p=0.033, d=0.35) and more strongly for the ADHD High Severity subgroup (N=22, t=3.33, p=0.003, d=0.71); the non-ADHD group showed no change (p=0.30).
- Spatial working memory improved for the ADHD group and ADHD High Severity subgroup on 8 of 12 CANTAB SWM variables each; BRIEF Working Memory improved significantly in the High Severity subgroup (p=0.014) and Inhibition improved significantly there (p=0.027), while the full ADHD group showed only a trend for Working Memory (p=0.07).
- Non-ADHD participants improved on 6 of 10 CANTAB Rapid Visual Processing variables and 9 of 16 Delayed Match to Sample variables, whereas ADHD improved on 3 of 10 RVP and 0 of 16 DMS variables.
Methods
- Open-label proof-of-concept study at 3 U.S. sites (January–August 2014) with 40 children with confirmed DSM-IV ADHD (M=10.3 years) and 40 age-matched non-ADHD children (M=10.5 years), ages 8–12; ADHD eligibility required ADHD-RS-IV ≥24 and being off ADHD medication for ≥1 week, while non-ADHD required ADHD-RS-IV ≤13.
- Participants completed 28 days of at-home Project: EVO, prescribed 30–45 minutes/day, 5 days/week (7 sessions/day), with screening and Day 28 post-intervention assessments; compliance was monitored electronically.
- Pre-post within-group analyses used paired t-tests or Wilcoxon tests, with Bonferroni corrections within statistical families; a post-hoc cut-point analysis defined the ADHD High Severity subgroup as ADHD-RS ≥30 and TOVA API ≤−1.8 (N=22).
Limitations
- The paper states that the open-label design may have allowed parent expectations to influence parent-report improvements, that real-world functional outcomes were not measured, that the sample may not represent all children with ADHD (e.g., unmedicated, no significant comorbid psychiatric disorders), and that exploratory multiple comparisons raise Type I error concerns despite Bonferroni corrections.
- Evident from the text: there was no randomization or blinded control group, analyses were per-protocol rather than intent-to-treat, noncompliant non-ADHD participants were dropped and replaced, the sample was small, and the High Severity subgroup was defined post-hoc.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 57 cited sources checked · 0 supported · 0 flagged
- Findingown data
In the ADHD High Severity subgroup, Reaction Time Variability (Variance) Standard Score improved significantly from pre- to post-intervention.
“Reaction Time Variability (Variance) Standard Score (T-Test; N = 22, t = 2.89, p = 0.009, Effect Size (d) = 0.62, mean of differences = -26.42, 95%CI-Lower = -45.42 95%CI-Upper = -7.43).”
Quote in the paperSubstantial claim - Findingown data
The ADHD High Severity subgroup showed significant improvement on 8 of 12 variables within the CANTAB SWM test.
“The ADHD High Severity subgroup showed significant improvement (p < 0.05) on 8 of 12 variables within the SWM, 0 of 10 variables within the RVP, and 1 of 16 within the DMS.”
Quote in the paperSubstantial claim - Findingown data
There was no change in API scores for the non-ADHD group (t=1.04, p=0.30, d=0.17, mean diff -0.39, 95% CI -1.16 to 0.37).
“There was no change in API scores for the non-ADHD group (T-Test; N = 40, t = 1.04, p = 0.30, Effect Size (d) = 0.17, mean of differences = -0.39, 95%CI-Lower = -1.16, 95%CI-Upper = 0.37).”
Quote in the paperNot a substantial claim- Rests on an assumption: The non-ADHD group provides a valid comparison for practice effects on the TOVA API.
- Findingown data
A total of 40 ADHD and 40 non-ADHD participants completed the study.
“A total of 40 ADHD and 40 non-ADHD participants completed the study.”
Quote in the paperNot a substantial claim - Findingown data
D-prime remained relatively constant in the ADHD High Severity subgroup.
“D-prime, a measure of signal detection sensitivity, remained relatively constant in both the ADHD group (p = 0.718) and the ADHD High Severity subgroup (p = 0.406).”
Quote in the paperNot a substantial claim
- Findingown data
D-prime remained relatively constant in the ADHD group.
“D-prime, a measure of signal detection sensitivity, remained relatively constant in both the ADHD group (p = 0.718) and the ADHD High Severity subgroup (p = 0.406).”
Quote in the paperNot a substantial claim - Findingown data
Average participant-reported enjoyment rating for EVO treatment was 6.9 on a 1-10 scale (ADHD M = 6.93; High Severity M = 7.1; non-ADHD M = 6.85).
“Results from the questionnaire on intervention appeal showed an average participant-reported enjoyment rating for EVO treatment of 6.9 on a 1–10 scale (ADHD M = 6.93; ADHD High Severity subgroup M = 7.1; non-ADHD M = 6.85).”
Quote in the paperSubstantial claim - Findingown data
The non-ADHD group showed significant improvement on 5 of 12 variables within the CANTAB SWM test.
“The non-ADHD group showed significant improvement (p < 0.05) on 5 of 12 variables within the SWM, 6 of 10 variables within the RVP, and 9 of 16 within the DMS.”
Quote in the paperNot a substantial claim - Findingown data
The non-ADHD group showed a decline in Omission Error Standard Score.
“Both the ADHD group (Wilcoxon; N = 40, z = 2.39, p = 0.016, Effect Size (r) = 0.38, mean of differences = 53.27, 95%CI-Lower = 3.34, 95%CI-Upper = 46.02) and the non-ADHD group (Wilcoxon; N = 40, z = 2.05, p = 0.040, Effect Size (r) = 0.32, mean of differences = 40.27, 95%CI-Lower = 0.32, 95%CI-Upper = 33.33) showed a decline in Omission Error Standard Score (i.e., missing targets).”
Quote in the paperNot a substantial claim - Findingown data
ExGaussian Tau improved significantly in the ADHD group.
“Analyses of the ExGaussian Tau, an experimental measure derived from the TOVA that may be a sensitive metric for attentional challenges, indicated significant improvement for both the ADHD group (T-Test; N = 40, t = 2.14, p = 0.039, Effect Size (d) = 0.34, mean of differences = 30.56, 95%CI-Lower = 1.7, 95%CI-Upper = 59.43)”
Quote in the paperSubstantial claim - Findingown data
The ADHD High Severity subgroup showed significant improvement on 0 of 10 variables within the CANTAB RVP test.
“The ADHD High Severity subgroup showed significant improvement (p < 0.05) on 8 of 12 variables within the SWM, 0 of 10 variables within the RVP, and 1 of 16 within the DMS.”
Quote in the paperNot a substantial claim - Findingown data
The ADHD group showed significant improvement on 0 of 16 variables within the CANTAB Delayed Match to Sample (DMS) test.
“The ADHD group showed significant improvement (p < 0.05) on 8 of 12 variables within the CANTAB Spatial Working Memory (SWM) test, 3 of 10 variables within the Rapid Visual Processing (RVP) test, and 0 of 16 within the Delayed Match to Sample (DMS) test.”
Quote in the paperNot a substantial claim - Findingown data
The non-ADHD group showed significant improvement on 9 of 16 variables within the CANTAB DMS test.
“The non-ADHD group showed significant improvement (p < 0.05) on 5 of 12 variables within the SWM, 6 of 10 variables within the RVP, and 9 of 16 within the DMS.”
Quote in the paperNot a substantial claim - Findingown data
ExGaussian Tau improved significantly in the ADHD High Severity subgroup.
“and the ADHD High Severity subgroup (T-Test; N = 22, t = 3.21, p = 0.004, Effect Size (d) = 0.69, mean of differences = 64.77, 95%CI-Lower = 22.85, 95%CI-Upper = 106.7)”
Quote in the paperSubstantial claim - Findingown data
The ADHD group showed a decline in Omission Error Standard Score.
“Both the ADHD group (Wilcoxon; N = 40, z = 2.39, p = 0.016, Effect Size (r) = 0.38, mean of differences = 53.27, 95%CI-Lower = 3.34, 95%CI-Upper = 46.02) and the non-ADHD group (Wilcoxon; N = 40, z = 2.05, p = 0.040, Effect Size (r) = 0.32, mean of differences = 40.27, 95%CI-Lower = 0.32, 95%CI-Upper = 33.33) showed a decline in Omission Error Standard Score (i.e., missing targets).”
Quote in the paperSubstantial claim - Findingown data
Across all participants, 84% of prescribed in-home sessions were completed.
“Across all participants, 84% of all prescribed in-home sessions were completed.”
Quote in the paperSubstantial claim - Findingown data
Significant improvements were observed on TOVA API in the ADHD group (t=2.21, p=0.033, d=0.35, mean diff -1.43, 95% CI -2.75 to -0.12).
“Significant improvements were observed on the TOVA primary composite measure, the Attention Performance Index (API) in the ADHD group (T-Test; N = 40, t = 2.21, p = 0.033, Effect Size (d) = 0.35, mean of differences = -1.43, 95%CI-Lower = -2.75, 95%CI-Upper = -0.12).”
Quote in the paperSubstantial claim- Rests on an assumption: Improvements in the ADHD group are attributable to the EVO intervention rather than practice effects, regression to the mean, or other nonspecific factors.
- Findingown data
The non-ADHD group showed significant improvement on 6 of 10 variables within the CANTAB RVP test.
“The non-ADHD group showed significant improvement (p < 0.05) on 5 of 12 variables within the SWM, 6 of 10 variables within the RVP, and 9 of 16 within the DMS.”
Quote in the paperNot a substantial claim - Findingown data
A larger effect of the intervention was observed for the ADHD High Severity subgroup (t=3.33, p=0.003, d=0.71, mean diff -3.05, 95% CI -4.96 to -1.15).
“In addition, a larger effect of the intervention was observed for the subset of ADHD participants with greater functional deficits and lower attentional performance (T-Test; N = 22, t = 3.33, p = 0.003, Effect Size (d) = 0.71, mean of differences = -3.05, 95%CI-Lower = -4.96, 95%CI-Upper = -1.15).”
Quote in the paperNot a substantial claim- Rests on an assumption: The ADHD High Severity subgroup's greater response is not due to regression to the mean or selection artifact.
- Findingown data
A cut-point analysis found the optimal cut-points for baseline ADHD-RS and TOVA API scores that define a subgroup of ADHD participants showing maximum change on TOVA API.
“A cut-point analysis was performed [31] to find the optimal cut-points for baseline ADHD-RS and TOVA API scores that would define a subgroup of ADHD participants that showed maximum change on the TOVA API.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] BA Williams, 2006, Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes
Not checked in the free run.
- Findingown data
The ADHD group showed significant improvement on 8 of 12 variables within the CANTAB Spatial Working Memory (SWM) test.
“The ADHD group showed significant improvement (p < 0.05) on 8 of 12 variables within the CANTAB Spatial Working Memory (SWM) test, 3 of 10 variables within the Rapid Visual Processing (RVP) test, and 0 of 16 within the Delayed Match to Sample (DMS) test.”
Quote in the paperSubstantial claim - Findingown data
None of the adverse events were reported during the practice session at the Screening Visit.
“None of the adverse events were reported during the practice session at the Screening Visit.”
Quote in the paperNot a substantial claim - Findingown data
Parent ratings of their child's enjoyment showed a similar pattern of overall enjoyment (ADHD M = 6.1; non-ADHD M = 6.6).
“Parent ratings of their child’s enjoyment showed a similar pattern of overall enjoyment (ADHD M = 6.1; non-ADHD M = 6.6).”
Quote in the paperNot a substantial claim - Findingown data
The ADHD group showed significant improvement on 3 of 10 variables within the CANTAB Rapid Visual Processing (RVP) test.
“The ADHD group showed significant improvement (p < 0.05) on 8 of 12 variables within the CANTAB Spatial Working Memory (SWM) test, 3 of 10 variables within the Rapid Visual Processing (RVP) test, and 0 of 16 within the Delayed Match to Sample (DMS) test.”
Quote in the paperNot a substantial claim - Findingown data
In the ADHD High Severity subgroup, Reaction Time Mean Standard Score improved significantly from pre- to post-intervention.
“The ADHD High Severity subgroup, but not the full ADHD group, showed significant improvements on two indicators of ADHD severity: Reaction Time Mean Standard Score (T-Test; N = 22, t = 3.03, p = 0.006, Effect Size (d) = 0.65, mean of differences = -13.16, 95%CI-Lower = -22.19, 95%CI-Upper = —4.13)”
Quote in the paperSubstantial claim - Findingown data
The ADHD High Severity subgroup showed significant improvement on 1 of 16 variables within the CANTAB DMS test.
“The ADHD High Severity subgroup showed significant improvement (p < 0.05) on 8 of 12 variables within the SWM, 0 of 10 variables within the RVP, and 1 of 16 within the DMS.”
Quote in the paperNot a substantial claim - Findingown data
The greatest change on TOVA API was observed with a sub-sample that had an ADHD-RS baseline score >= 30 and a TOVA API < -1.8.
“The results of this analysis indicated that the greatest change on TOVA API was observed with a sub-sample that had an ADHD-RS baseline score of > = 30 and a TOVA API < -1.8.”
Quote in the paperNot a substantial claim - Findingown data
Project: EVO resulted in positive ratings of acceptability by both parents and children.
“Project: EVO was well-tolerated by children with ADHD, was feasibly deployed in the home setting over a treatment period of four weeks, and resulted in positive ratings of acceptability by both parents and children.”
Quote in the paperSubstantial claim - Findingown data
Qualitative ratings provided by parents suggest that the vast majority describe the intervention as having value.
“Indeed, qualitative ratings provided by parents suggest that the vast majority describe the intervention as having value, and a majority of parents believed it was worthwhile enough to report the desire for access to the intervention after the study period.”
Quote in the paperSubstantial claim - Findingown data
BRIEF Metacognition summary scores did not change significantly over time for any group.
“In addition, the BRIEF summary scores (i.e., Metacognition, Behavioral Regulation, Global Executive Composite) did not change significantly over time for any of the groups.”
Quote in the paperNot a substantial claim - Findingown data
Project: EVO was feasibly deployed in the home setting over a treatment period of four weeks.
“Project: EVO was well-tolerated by children with ADHD, was feasibly deployed in the home setting over a treatment period of four weeks, and resulted in positive ratings of acceptability by both parents and children.”
Quote in the paperSubstantial claim - Findingown data
In the non-ADHD group, Working Memory scores did not change significantly.
“The Working Memory and Inhibit scores did not change significantly for the non-ADHD group.”
Quote in the paperNot a substantial claim - Findingown data
In the ADHD High Severity subgroup, Inhibition percentile scores improved significantly.
“For the ADHD High Severity subgroup, percentile scores on Working Memory (Wilcoxon; N = 22, z = 2.40, p = 0.014, Effect Size (r) = 0.51, mean of differences = 3.23, 95%CI-Lower = 1, 95%CI-Upper = 7.5) and Inhibition (Wilcoxon; N = 22, z = 2.19, p = 0.027, Effect Size (r) = 0.47, mean of differences = 5.68, 95%CI-Lower = 1, 95%CI-Upper = 15.5) improved significantly.”
Quote in the paperSubstantial claim - Findingown data
BRIEF Behavioral Regulation summary scores did not change significantly over time for any group.
“In addition, the BRIEF summary scores (i.e., Metacognition, Behavioral Regulation, Global Executive Composite) did not change significantly over time for any of the groups.”
Quote in the paperNot a substantial claim - Findingown data
Project: EVO was well-tolerated by children with ADHD.
“Project: EVO was well-tolerated by children with ADHD, was feasibly deployed in the home setting over a treatment period of four weeks, and resulted in positive ratings of acceptability by both parents and children.”
Quote in the paperSubstantial claim - Findingown data
Engaging with Project: EVO's regimen was associated with statistically significant improvements in attention and impulsivity, as measured by TOVA API and other component TOVA metrics.
“Engaging with Project: EVO’s regimen was associated with statistically significant improvements in attention and impulsivity, as measured by TOVA API and other component TOVA metrics.”
Quote in the paperSubstantial claim - Findingown data
In the ADHD High Severity subgroup, Working Memory percentile scores improved significantly.
“For the ADHD High Severity subgroup, percentile scores on Working Memory (Wilcoxon; N = 22, z = 2.40, p = 0.014, Effect Size (r) = 0.51, mean of differences = 3.23, 95%CI-Lower = 1, 95%CI-Upper = 7.5) and Inhibition (Wilcoxon; N = 22, z = 2.19, p = 0.027, Effect Size (r) = 0.47, mean of differences = 5.68, 95%CI-Lower = 1, 95%CI-Upper = 15.5) improved significantly.”
Quote in the paperSubstantial claim - Findingown data
A majority of parents believed the intervention was worthwhile enough to report the desire for access to the intervention after the study period.
“Indeed, qualitative ratings provided by parents suggest that the vast majority describe the intervention as having value, and a majority of parents believed it was worthwhile enough to report the desire for access to the intervention after the study period.”
Quote in the paperSubstantial claim - Findingown data
In the non-ADHD group, Inhibit scores did not change significantly.
“The Working Memory and Inhibit scores did not change significantly for the non-ADHD group.”
Quote in the paperNot a substantial claim - Findingown data
40% of parents did not indicate a desire to continue the intervention.
“Importantly, despite 80% of parents indicating that the intervention was somewhat or very worthwhile, 40% of parents did not indicate a desire to continue the intervention.”
Quote in the paperNot a substantial claim - Findingown data
80% of parents indicated that the intervention was somewhat or very worthwhile.
“Importantly, despite 80% of parents indicating that the intervention was somewhat or very worthwhile, 40% of parents did not indicate a desire to continue the intervention.”
Quote in the paperSubstantial claim - Findingown data
Positive performance trajectories of children with ADHD and non-ADHD participants without ADHD were objectively demonstrated via several standardized outcome measures.
“The positive performance trajectories of children with ADHD and non-ADHD participants without ADHD were objectively demonstrated via several standardized outcome measures; however, next studies will need to include additional measures of real-world outcomes in order to determine if the cognitive improvements translate to everyday functioning.”
Quote in the paperSubstantial claim - Findingown data
BRIEF Global Executive Composite summary scores did not change significantly over time for any group.
“In addition, the BRIEF summary scores (i.e., Metacognition, Behavioral Regulation, Global Executive Composite) did not change significantly over time for any of the groups.”
Quote in the paperNot a substantial claim - Premisecitation
Pharmacological and behavioral therapies have limited impact on the distinct neurocognitive impairments associated with ADHD.
“Pharmacological and behavioral therapies have limited impact on the distinct neurocognitive impairments associated with ADHD”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [10] RH Pietrzak, 2006, Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder, Neuroscience and Biobehavioral Reviews source
Not checked in the free run.
- cites [11] J Biederman, 2015, Evidence of a pharmacological dissociation between the robus effects of methylphenidcate on ADHD symptoms and weaker effects on working memory, Journal of Brain Sciences source
Not checked in the free run.
- Premisecitation
Pharmacological treatment for ADHD lacks normalization even in well-titrated doses.
“lack of normalization even in well-titrated doses [9]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] BC O'Connor, 2015, Improved but still impaired: symptom-impairment correspondence among youth with attention-deficit hyperactivity disorder receiving community-based care, Journal of Developmental and Behavioral Pediatrics source
Not checked in the free run.
- Premisecitation
Recent evidence suggests pharmacological treatment may not show optimal benefits in some neurocognitive domains.
“Recent evidence also suggests that pharmacological treatment may not show optimal benefits in some neurocognitive domains [10, 11].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [10] RH Pietrzak, 2006, Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder, Neuroscience and Biobehavioral Reviews source
Not checked in the free run.
- cites [11] J Biederman, 2015, Evidence of a pharmacological dissociation between the robus effects of methylphenidcate on ADHD symptoms and weaker effects on working memory, Journal of Brain Sciences source
Not checked in the free run.
- Premisecitation
Existing cognitive training programs have shown limited efficacy.
“existing cognitive training programs have shown limited efficacy.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [18] M van Dongen-Boomsma, 2014, Working memory training in young children with ADHD: a randomized placebo-controlled trial, Journal of Child Psychology and Psychiatry and Allied Disciplines source
Not checked in the free run.
- cites [19] S Cortese, 2015, Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials, Journal of the American Academy of Child and Adolescent Psychiatry source
Not checked in the free run.
- cites [20] MD Rapport, 2013, Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes, Clinical Psychology Review source
Not checked in the free run.
- Premisecitation
Pharmacological treatment for ADHD has limitations including unfavorable side effects for some patients.
“pharmacological treatment has limitations including unfavorable side effects for some patients [8]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] SR Pliszka, 2007, Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action, Neuropsychology Review source
Not checked in the free run.
- Premisecitation
Gazzaley and colleagues demonstrated that a game-like cognitive intervention built to target a critical neural process underlying cognitive control can achieve cognitive remediation.
“Gazzaley and colleagues identified a critical neural process underlying cognitive control ability, and demonstrated that a game-like cognitive intervention built to specifically target this system can achieve cognitive remediation [22, 23].”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Current evidence-based treatments were not explicitly designed to address the underlying pathophysiology associated with ADHD.
“current evidence-based treatments were not explicitly designed to address the underlying pathophysiology that is associated with ADHD”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] A Chacko, 2014, Improving outcomes for youth with ADHD: a conceptual framework for combined neurocognitive and skill-based treatment approaches, Clinical Child and Family Psychology Review source
Not checked in the free run.
- Premisecitation
Behavioral therapy for ADHD can be difficult to access.
“treatment can be difficult to access”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] EJ Sonuga-Barke, 2013, Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments, American Journal of Psychiatry source
Not checked in the free run.
- cites [14] J Coates, 2015, Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis, Journal of Attention Disorders source
Not checked in the free run.
- Interpretationown data
Findings provide preliminary support that the treatment may improve working memory in children with ADHD.
“Findings provide preliminary support that this treatment may improve attention, working memory, and inhibition in children with ADHD.”
Quote in the paperSubstantial claim - Premisecitation
Effects of behavioral therapy are often not maintained outside the treatment period.
“effects of behavioral therapy are often not maintained outside the treatment period”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] EJ Sonuga-Barke, 2013, Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments, American Journal of Psychiatry source
Not checked in the free run.
- cites [14] J Coates, 2015, Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis, Journal of Attention Disorders source
Not checked in the free run.
- Premisecitation
Project: EVO is a digital treatment based on the Neuroracer model that deploys interference-based cognitive control-targeting mechanics in a high-quality action video game-like interface.
“Project: EVO (EVO) is a digital treatment based on the Neuroracer model that deploys the interference-based cognitive control-targeting mechanics in a high-quality action video game-like interface.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] JA Anguera, 2013, Video game training enhances cognitive control in older adults, Nature source
Not checked in the free run.
- Interpretationown data
Findings provide preliminary support that the treatment may improve inhibition in children with ADHD.
“Findings provide preliminary support that this treatment may improve attention, working memory, and inhibition in children with ADHD.”
Quote in the paperSubstantial claim - Premisecitation
A recent meta-analysis raised questions about the efficacy of behavioral therapy for improving ADHD symptoms.
“a recent meta-analysis raised questions about its efficacy for improving ADHD symptoms [13, 14]”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] EJ Sonuga-Barke, 2013, Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments, American Journal of Psychiatry source
Not checked in the free run.
- cites [14] J Coates, 2015, Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis, Journal of Attention Disorders source
Not checked in the free run.
- Interpretationown data
Findings provide preliminary support that the treatment may improve attention in children with ADHD.
“Findings provide preliminary support that this treatment may improve attention, working memory, and inhibition in children with ADHD.”
Quote in the paperSubstantial claim- Rests on an assumption: Improvements in the ADHD group are attributable to the EVO intervention rather than practice effects, regression to the mean, or other nonspecific factors.
- Study design and conductown data
An Intent To Treat analysis was not considered necessary due to the low drop rate.
“An Intent To Treat (ITT) analysis was not considered necessary due to the low drop rate.”
Quote in the paperSubstantial claim - Premisecitation
Adherence and compliance to both pharmacological and behavioral treatment regimens is often quite poor.
“Critically, adherence and compliance to both pharmacological and behavioral treatment regimens is often quite poor [15].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] K Gajria, 2014, Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder—a systematic literature review, Neuropsychiatr Dis Treat
Not checked in the free run.
- Premisecitation
Documented dropout rates in traditional treatment trials and real-world settings exceed 10%.
“documented dropout rates of >10% in traditional treatment trials as well as real-world settings [15, 32].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [15] K Gajria, 2014, Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder—a systematic literature review, Neuropsychiatr Dis Treat
Not checked in the free run.
- cites [32] SL Toomey, 2012, Why do children with ADHD discontinue their medication?, Clinical Pediatrics source
Not checked in the free run.
- Interpretationcitation
It is likely that the current study reflects effects that are well above the impact of a placebo or expectation bias.
“so it is likely that the current study reflects effects that are well above the impact of a placebo or expectation bias.”
Quote in the paperSubstantial claim - Premisecitation
The BRIEF parent-report provides important clinical information about functional deficits associated with ADHD.
“For example, the BRIEF parent-report provides important clinical information about functional deficits associated with ADHD, and has been correlated with both neuroanatomy and performance on working memory measures [44, 45].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [44] ME Toplak, 2009, Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD), Child Neuropsychology source
Not checked in the free run.
- cites [45] N Faridi, 2015, Neuroanatomical correlates of behavioral rating versus performance measures of working memory in typically developing children and adolescents, Neuropsychology source
Not checked in the free run.
- Study design and conductown data
There was high compliance in the ADHD cohort.
“Notably, there was high compliance and no dropouts in the ADHD cohort.”
Quote in the paperSubstantial claim - Interpretationown data
Results suggest that the BRIEF may provide a useful proxy for understanding the effects of EVO on aspects of executive functioning such as working memory and inhibition.
“Although only a subset of BRIEF scales was examined in the current analyses, results suggest that this measure may provide a useful proxy for understanding the effects of EVO on aspects of executive functioning such as working memory and inhibition.”
Quote in the paperSubstantial claim - Premisecitation
Access to behavioral treatments is limited when interventions can only be given by trained providers in a clinic setting.
“yet access to behavioral treatments is limited when interventions can only be given by trained providers in a clinic setting.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [33] AL Krain, 2005, The role of treatment acceptability in the initiation of treatment for ADHD, Journal of Attention Disorders source
Not checked in the free run.
- cites [34] C Johnston, 2008, Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics, Behavior Therapy source
Not checked in the free run.
- Study design and conductown data
There were no dropouts in the ADHD cohort.
“Notably, there was high compliance and no dropouts in the ADHD cohort.”
Quote in the paperSubstantial claim - Interpretationreasoning
Findings suggest generalizability of benefits to outcome measures that are different in design and that tap domains that differ from the intervention itself.
“In the current work, findings suggest generalizability of benefits to outcome measures that are different in design and that tap domains that differ from the intervention itself.”
Quote in the paperSubstantial claim - Interpretationown data
Results of this study suggest that moderate improvements across a range of working memory and processing measurements on the CANTAB resulted from EVO treatment.
“The results of this study suggest that moderate improvements across a range of working memory and processing measurements on the CANTAB resulted from EVO treatment.”
Quote in the paperSubstantial claim - Interpretationreasoning
The BRIEF parent-report measure may be less sensitive to effects of the intervention than computer-based measures because the constructs are somewhat distinct.
“At the same time, this parent-report measure may be less sensitive to effects of the intervention than the computer-based measures because the constructs are somewhat distinct.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The representativeness of the ADHD sample may affect the generalizability of these preliminary findings.
“In addition, study participants with ADHD represented a subset of the pediatric general population, but may not be representative of the entire general population of children with ADHD (e.g., not on medication, no significant co-morbid psychiatric disorders) which may affect the generalizability of these preliminary findings.”
Quote in the paperSubstantial claim - Premisecitation
Executive function profiles of individuals with ADHD are extremely heterogeneous.
“although the executive function profiles of individuals with ADHD are extremely heterogeneous, the presence of such deficits confers risk for more significant the impairment [41, 42].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] BA Roberts, 2013, Are There Executive Dysfunction Subtypes Within ADHD?, Journal of Attention Disorders
Not checked in the free run.
- cites [42] EG Willcutt, 2005, Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review, Biological Psychiatry source
Not checked in the free run.
- Premisecitation
Medication management is the most commonly utilized treatment for ADHD.
“medication management, the mostly commonly utilized treatment for ADHD, has a very significant effect on core symptoms of ADHD but only equivocal effects on specific executive functions [38–40].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] P Hammerness, 2014, Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD, Child Neuropsychology source
Not checked in the free run.
- cites [39] J Swanson, 2011, Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress, Neuropsychopharmacology source
Not checked in the free run.
- cites [40] SS Gau, 2010, Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine, International Journal of Neuropsychopharmacology source
Not checked in the free run.
- Premisecitation
The presence of executive function deficits in ADHD confers risk for more significant impairment.
“although the executive function profiles of individuals with ADHD are extremely heterogeneous, the presence of such deficits confers risk for more significant the impairment [41, 42].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [41] BA Roberts, 2013, Are There Executive Dysfunction Subtypes Within ADHD?, Journal of Attention Disorders
Not checked in the free run.
- cites [42] EG Willcutt, 2005, Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review, Biological Psychiatry source
Not checked in the free run.
- Premisecitation
Research on treatment acceptability suggests high acceptability ratings for behavioral compared to pharmacological treatment.
“research on treatment acceptability suggests high acceptability ratings for behavioral as compared to pharmacological treatment [33, 34]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [33] AL Krain, 2005, The role of treatment acceptability in the initiation of treatment for ADHD, Journal of Attention Disorders source
Not checked in the free run.
- cites [34] C Johnston, 2008, Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics, Behavior Therapy source
Not checked in the free run.
- Interpretationreasoning
Results from TOVA metrics support modest transfer of benefit effects given the noted differences in platforms.
“Taken together, results from TOVA metrics support modest transfer of benefit effects given the noted differences in platforms.”
Quote in the paperSubstantial claim - Premisecitation
The TOVA test of attentional functioning has traditionally shown little to no placebo response.
“However, research on cognitive training methods suggests a much smaller magnitude of improvement [46], and the TOVA test of attentional functioning has traditionally shown little to no placebo response [47]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] N Vaisman, 2008, Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids, Am J Clin Nutr source
Not checked in the free run.
- Interpretationreasoning
The consumer-grade videogame-like format and self-administered at-home design of Project: EVO may enhance motivation and acceptability in real-world treatment deployment.
“Additionally and uniquely, Project: EVO is designed to appeal to children through a consumer-grade videogame-like format and a user-friendly at-home intervention that can be self-administered, both of which may enhance motivation and acceptability in real-world treatment deployment.”
Quote in the paperSubstantial claim - Study design and conductnone given
The current study was an open-label, proof-of-concept trial.
“In addition, because the current study was an open-label, proof-of-concept trial, it is possible that any improvements observed via parent report were influenced by parent expectations of benefit that would be received from the intervention.”
Quote in the paperSubstantial claim - Premisecitation
Research on cognitive training methods suggests a much smaller magnitude of improvement.
“However, research on cognitive training methods suggests a much smaller magnitude of improvement [46], and the TOVA test of attentional functioning has traditionally shown little to no placebo response [47]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] JL Hardy, 2015, Enhancing Cognitive Abilities with Comprehensive Training: A Large, Online, Randomized, Active-Controlled Trial, PLoS One source
Not checked in the free run.
- Classified as probably not a substantial claim. 25
- May combine two claims. 28
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataA total of 87 participants were screened and 3 were screen fails.
“A total of 87 participants were screened for the study and a total of 3 participants were screen fails.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere were only 4 participants who dropped out of the study, and none of these participants were in the ADHD cohort.
“Additionally, there were only 4 participants who dropped out of the study, and none of these participants were in the ADHD cohort.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCompliance rates did not differ significantly between ADHD and non-ADHD groups, ADHD and ADHD High Severity subgroup, or non-ADHD and ADHD High Severity subgroup.
“There were no significant differences found between the ADHD and non-ADHD groups (p = 0.20), the ADHD and ADHD High Severity subgroup (p = 0.38), or the non-ADHD and the ADHD High Severity subgroup (p = 0.30).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAll ADHD group participants were compliant with the intervention and none were replaced.
“All of the ADHD group participants were compliant with the intervention and none of these participants were replaced during the study.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFour participants from the non-ADHD group were dropped for poor compliance, representing a replacement rate of 5% of the total study final sample size.
“Four participants from the non-ADHD group were dropped from the study for poor compliance, which represents a replacement rate of 5% of the total study final sample size.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe full ADHD group did not show significant improvement on Reaction Time Mean Standard Score or Reaction Time Variability (Variance) Standard Score.
“The ADHD High Severity subgroup, but not the full ADHD group, showed significant improvements on two indicators of ADHD severity”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSpatial working memory also improved for the ADHD group and the ADHD High Severity subgroup.
“Spatial working memory also improved for the ADHD group and the ADHD High Severity subgroup.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataFour participants from the non-ADHD group were dropped for non-compliance and were replaced.
“During the intervention period, four participants from the non-ADHD group were dropped from the study for non-compliance with the at-home intervention use. These participants were replaced by recruiting additional participants.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA total of 9 adverse events were reported over all study phases; none were judged by PIs and site staff as related to EVO.
“A total of 9 adverse events were reported over all study phases; however, none of those adverse events were judged by the PIs and site staff as related to EVO (Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ADHD group completed an average of 81% of required at-home sessions, the ADHD High Severity subgroup 86%, and the non-ADHD group 87%.
“The ADHD group completed an average of 81% (10.8 hours of intervention), the ADHD High Severity subgroup completed an average of 86% (11.1 hours of intervention), while the non-ADHD group completed an average of 87% (11.5 hours of intervention) of the required at-home sessions.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ADHD High Severity subgroup was selected via post-hoc statistical analyses and demonstrated a greater response to the intervention.
“A subset of participants from the ADHD group was subsequently selected via post-hoc statistical analyses to comprise the ADHD High Severity group. As described further below and characterized in Table 1, this subset of participants demonstrated a greater response to the intervention.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the ADHD group, Working Memory percentile scores improved non-significantly but showed a trend-level effect.
“On the Working Memory subscale, percentile scores for the ADHD group improved non-significantly but a trend-level effect was observed (Wilcoxon; N = 40, z = 1.81, p = 0.07, Effect Size (r) = 0.29, mean of differences = 2.48, 95%CI-Lower = 0.0, 95%CI-Upper = 5.5) (Table 4).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningOnly participants who completed the at-home period and final assessments were included in the analysis, therefore no missing data was present.
“Only participants who completed the at-home period and completed the final assessments were included in the analysis, therefore no missing data was present.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningThe study was open-label; participants and study staff were not blinded to study condition.
“Given the open-label design, participants and study staff were not blinded to study condition.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe MINI-KID has demonstrated concordance to other structured psychiatric interviews and can be implemented using parent report.
“It has demonstrated concordance to other structured psychiatric interviews and can be implemented using parent report.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] DV Sheehan, 2010, Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID), Journal of Clinical Psychiatry source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenThe sample size was chosen to be sufficiently large to detect significant within-subject effects of at least 0.45 (Cohen's D) for a 2-tailed test, at alpha 0.05 with 80% power.
“Given the exploratory nature of the study, the sample size was chosen to be sufficiently large to detect significant within subject effects of at least 0.45 (Cohen’s D) for a 2-Tailed test, at anlpha-0.05 with a power of 80%.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEquivocal findings from meta-analyses of cognitive training programs have been reported, such as inadequate generalizability of effects outside of training and limitations of addressing cognitive processes versus core symptoms.
“equivocal findings from meta-analyses have been reported, such as inadequate generalizability of effects outside of training and the limitations of addressing cognitive processes versus core symptoms [18–20].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [18] M van Dongen-Boomsma, 2014, Working memory training in young children with ADHD: a randomized placebo-controlled trial, Journal of Child Psychology and Psychiatry and Allied Disciplines source
Not checked in the free run.
- cites [19] S Cortese, 2015, Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials, Journal of the American Academy of Child and Adolescent Psychiatry source
Not checked in the free run.
- cites [20] MD Rapport, 2013, Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes, Clinical Psychology Review source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitationThe ADHD-RS is an 18-item validated scale completed via semi-structured interview with the parent to assess symptom severity.
“The ADHD-RS is an 18-item validated scale that is completed via semi-structured interview with the participant’s parent to assess symptom severity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] G DuPaul, 1998, ADHD Rating Scale-IV: Checklist, norms, and clinical interpretation
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationThe TOVA is a computerized continuous performance test that objectively measures attention and impulsivity.
“The TOVA is a computerized continuous performance test that objectively measures attention and impulsivity”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] LM Greenberg, 2007, Test of Variables of Attention Clinical Manual
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe C-SSRS has been well-validated for use in clinical trials.
“It has been well-validated for use in clinical trials.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26] K Posner, 2011, The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults, American Journal of Psychiatry source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationAfter completing the Neuroracer regimen, changes in EEG signals occurred at neurological loci associated with cognitive control.
“they showed that changes in EEG signals occurred at neurological loci associated with cognitive control after completing the prescribed therapeutic regimen.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] JA Anguera, 2013, Video game training enhances cognitive control in older adults, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn older adults, Neuroracer reduced interference susceptibility and cognitive benefits transferred to untrained tests of attention, impulsivity, and multitasking.
“Results of the study indicated that interference susceptibility was reduced and demonstrated that cognitive benefits transferred to performance on untrained tests of attention, impulsivity, and multitasking [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] JA Anguera, 2013, Video game training enhances cognitive control in older adults, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study was reviewed and approved by the Copernicus Group IRB on 8/28/2013.
“This study was reviewed and approved by the Copernicus Group IRB on 8/28/2013 (IRB Tracking #: AKI1-13-296).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe ADHD High Severity sub-sample had 22 participants (mean age = 10.2, 14 males and 8 females) and did not differ in terms of age or gender.
“This sub-sample had 22 participants (mean age = 10.2, 14 males and 8 females), and did not differ in terms of age or gender.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationImprovements in multi-tasking were maintained in the Neuroracer treatment group after 6 months of no treatment, and this maintenance correlated with EEG-based neurological changes.
“Improvements in multi-tasking were maintained in the treatment group after 6 months of no treatment, and this maintenance effect also correlated with the same EEG-based neurological changes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] JA Anguera, 2013, Video game training enhances cognitive control in older adults, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWritten consent was obtained from parents/caregivers of all participants prior to completing study procedures.
“Written consent was obtained from parents/caregivers of all participants prior to completing study procedures.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Study design and conductnone givenFor each variable and group, the normality assumption for T-Tests was verified using a Shapiro-Wilks test.
“For each variable and group, the normality assumption for T-Tests was verified using a Shapiro-Wilks test.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMedication management has a very significant effect on core symptoms of ADHD but only equivocal effects on specific executive functions.
“medication management, the mostly commonly utilized treatment for ADHD, has a very significant effect on core symptoms of ADHD but only equivocal effects on specific executive functions [38–40].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] P Hammerness, 2014, Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD, Child Neuropsychology source
Not checked in the free run.
- cites [39] J Swanson, 2011, Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress, Neuropsychopharmacology source
Not checked in the free run.
- cites [40] SS Gau, 2010, Improvement of executive functions in boys with attention deficit hyperactivity disorder: an open-label follow-up study with once-daily atomoxetine, International Journal of Neuropsychopharmacology source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationDeficits observed on the CANTAB among individuals with ADHD improve in the context of stimulant treatment.
“Similarly, deficits observed on the CANTAB among individuals with ADHD improve in the context of stimulant treatment, suggesting these are key targets for other novel interventions for this disorder [38].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] P Hammerness, 2014, Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD, Child Neuropsychology source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIf the Shapiro-Wilks test indicated that the distribution of scores did not meet normality, a Wilcoxon rank sum test was performed instead.
“If the Shapiro-Wilks test indicated that the distribution of scores did not meet normality, a Wilcoxon rank sum test was performed instead.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningThe current study reports Bonferroni corrected significance values to address the concern of Type I error.
“The current study reports Bonferroni corrected significance values to address this concern; however, future studies will need to replicate the current findings with a priori hypotheses to confirm these exploratory findings.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataStatistical significance for some outcomes was determined after a Bonferroni correction of 0.05/5 = 0.01.
“** indicates statistical significance after a Bonferroni correction of 0.05/5 = 0.01.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenStudy participants with ADHD represented a subset of the pediatric general population, but may not be representative of the entire general population of children with ADHD (e.g., not on medication, no significant co-morbid psychiatric disorders).
“In addition, study participants with ADHD represented a subset of the pediatric general population, but may not be representative of the entire general population of children with ADHD (e.g., not on medication, no significant co-morbid psychiatric disorders) which may affect the generalizability of these preliminary findings.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe ADHD groups' improved Attention Performance index and maintenance of D-prime, despite a decrease in the omission error standard score, may imply attentional improvements that accompany and are not compromised by a shift to a more cautious/withholding response profile.
“Interestingly, the ADHD groups’ improved Attention Performance index and maintenance of D-prime, despite a decrease in the omission error standard score, may imply attentional improvements that accompany and are not compromised by a shift to a more cautious/withholding response profile.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataOverall, the results suggest improvement in Spatial Working Memory (SWM) for the ADHD and ADHD High Severity subgroups, and improvements for the non-ADHD group on Rapid Visual Processing (RVP) and Delayed Match to Sample (DMS).
“Overall, the results suggest an improvement for Spatial Working Memory (SWM) for the ADHD and ADHD High Severity subgroup and well as improvements for the non-ADHD group on Rapid Visual Processing (RVP) and Delayed Match to Sample (DMS).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenDelivery of a digital treatment intervention on a mobile device may increase compliance by making the treatment enjoyable and comfortable for use in an at-home setting.
“Delivery of a digital treatment intervention on a mobile device may increase access to treatment, reduce cost of care, and increase compliance by making the treatment enjoyable and comfortable for use in an at-home setting.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningDelivery of a digital treatment intervention on a mobile device may reduce cost of care.
“Delivery of a digital treatment intervention on a mobile device may increase access to treatment, reduce cost of care, and increase compliance by making the treatment enjoyable and comfortable for use in an at-home setting.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationParent acceptability of ADHD treatment is influenced by multiple factors.
“consistent with prior research that parent acceptability of ADHD treatment is influenced by multiple factors [37].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] NK Schatz, 2015, Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care, Patient source
Not checked in the free run.
May combine two claims.
PremisecitationThe BRIEF parent-report has been correlated with both neuroanatomy and performance on working memory measures.
“For example, the BRIEF parent-report provides important clinical information about functional deficits associated with ADHD, and has been correlated with both neuroanatomy and performance on working memory measures [44, 45].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [44] ME Toplak, 2009, Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD), Child Neuropsychology source
Not checked in the free run.
- cites [45] N Faridi, 2015, Neuroanatomical correlates of behavioral rating versus performance measures of working memory in typically developing children and adolescents, Neuropsychology source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningDelivery of a digital treatment intervention on a mobile device may increase access to treatment.
“Delivery of a digital treatment intervention on a mobile device may increase access to treatment, reduce cost of care, and increase compliance by making the treatment enjoyable and comfortable for use in an at-home setting.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationOther computerized cognitive training programs have demonstrated positive outcomes on executive tasks similar to trained tasks but limited generalization to other tasks.
“Results of the study build upon those reported for other computerized cognitive training programs that have demonstrated positive outcomes on executive tasks that are similar to trained tasks but have shown limited generalization to other tasks [35, 36].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] T Klingberg, 2010, Training and plasticity of working memory, Trends in Cognitive Sciences source
Not checked in the free run.
- cites [36] S Dovis, 2015, Improving executive functioning in children with ADHD: training multiple executive functions within the context of a computer game. a randomized double-blind placebo controlled trial, PLoS One source
Not checked in the free run.
May combine two claims.
Interpretationown dataFindings from the current study provide preliminary support that this digital therapy intervention may be effective for improving attention, working memory, and inhibition in pediatric ADHD, especially among children with greater symptom severity and impaired attention.
“Findings from the current study provide preliminary support that this digital therapy intervention may be effective for improving attention, working memory, and inhibition in pediatric ADHD, especially among children with greater symptom severity and impaired attention.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningIt is possible that any improvements observed via parent report were influenced by parent expectations of benefit.
“In addition, because the current study was an open-label, proof-of-concept trial, it is possible that any improvements observed via parent report were influenced by parent expectations of benefit that would be received from the intervention.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Improvements in the ADHD group are attributable to the EVO intervention rather than practice effects, regression to the mean, or other nonspecific factors.
“Significant improvements were observed on the TOVA primary composite measure, the Attention Performance Index (API) in the ADHD group (T-Test; N = 40, t = 2.21, p = 0.033, Effect Size (d) = 0.35, mean of differences = -1.43, 95%CI-Lower = -2.75, 95%CI-Upper = -0.12).”
The paper relies on this without support.
The ADHD High Severity subgroup's greater response is not due to regression to the mean or selection artifact.
“In addition, a larger effect of the intervention was observed for the subset of ADHD participants with greater functional deficits and lower attentional performance (T-Test; N = 22, t = 3.33, p = 0.003, Effect Size (d) = 0.71, mean of differences = -3.05, 95%CI-Lower = -4.96, 95%CI-Upper = -1.15).”
The paper relies on this without support.
The 84% completion rate and appeal ratings indicate acceptable treatment acceptability.
“Across all participants, 84% of all prescribed in-home sessions were completed.”
The paper relies on this without support.
The non-ADHD group provides a valid comparison for practice effects on the TOVA API.
“There was no change in API scores for the non-ADHD group (T-Test; N = 40, t = 1.04, p = 0.30, Effect Size (d) = 0.17, mean of differences = -0.39, 95%CI-Lower = -1.16, 95%CI-Upper = 0.37).”
The paper relies on this without support.
Prior work with Neuroracer showed that participants who received the digital intervention demonstrated improvements in attentional functioning and spatial working memory as measured by accepted computerized tests over a one-month intervention period.
“As shown in prior work with Neuroracer, the platform upon which Project: EVO was developed, participants who received the digital intervention demonstrated improvements in attentional functioning and spatial working memory as measured by accepted computerized tests over the one-month intervention period.”
The paper relies on this without support.
Medication is the front line treatment for children with ADHD.
“Although medication is the front line treatment for children with ADHD, there remains a need for the development of alternative intervention modalities to optimize care for these patients.”
The paper relies on this without support.
The ExGaussian Tau may be a sensitive metric for attentional challenges.
“Analyses of the ExGaussian Tau, an experimental measure derived from the TOVA that may be a sensitive metric for attentional challenges, indicated significant improvement for both the ADHD group (T-Test; N = 40, t = 2.14, p = 0.039, Effect Size (d) = 0.34, mean of differences = 30.56, 95%CI-Lower = 1.7, 95%CI-Upper = 59.43)”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The proportions of responders at the end of treatment phase for primary and secondary endpoints were prespecified on the basis of previous studies.
“The proportions of responders at the end of treatment phase for primary and secondary endpoints were prespecified on the basis of previous studies, 20,24”
From A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial (2020) · cites this paper as [20]
The current study findings of improved attention via TOVA API following treatment with AKL-T01 are consistent with benefits reported in previous uncontrolled studies.
“The current study findings of improved attention (via TOVA API) following treatment with AKL-T01 are consistent with benefits reported in previous uncontrolled studies.18,20”
From A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial (2020) · cites this paper as [20]
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = 2.39reported p = .016 · recomputed p = .017
“z = 2.39, p = .016”
The paper states an exact rank test
- Consistentz = 2.05reported p = .04 · recomputed p = .040
“z = 2.05, p = .040”
- Consistentz = 1.81reported p = .07 · recomputed p = .070
“z = 1.81, p = .07”
- Consistentz = 2.4reported p = .014 · recomputed p = .016
“z = 2.40, p = .014”
The paper states an exact rank test
- Consistentz = 2.19reported p = .027 · recomputed p = .029
“z = 2.19, p = .027”
The paper states an exact rank test
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Overall intervention hours do not match the two group averages
MinorThe ADHD and non-ADHD groups each had 40 participants, so their reported averages of 10.8 and 11.5 hours imply an overall average of 11.15 hours, not approximately 10.9 hours.
Reported 10.9 · recomputed 11.15
“This is equal to approximately 10.9 hours of total intervention time per child across the approximately 28-day intervention period. The ADHD group completed an average of 81% (10.8 hours of intervention), the ADHD High Severity subgroup completed an average of 86% (11.1 hours of intervention), while the non-ADHD group completed an average of 87% (11.5 hours of intervention)”
Working-memory result is marked significant after a correction it does not pass
MinorThe ADHD High Severity subgroup's working-memory result has p = 0.014 and is marked with **, but the table defines ** as significance after correction to a threshold of 0.01. Since 0.014 exceeds 0.01, the corrected-significance marker is inconsistent with the reported p-value.
“| Working Memory Percentile | ADHD High Severity Subgroup | 22 | 95.591(4.982) | 92.364(8.375)** | 2.404(Z) | 0.014 | 0.475(0.513) | (1\|7.5) |”
“** indicates statistical significance after a Bonferroni correction of 0.05/5 = 0.01.”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,468 · see citing works
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157 · see citing works
Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.006 · Cited by 3,568 · see citing works
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185 · see citing works
Sheehan, D. V., Sheehan, K. H., Shytle, R. D., Janavs, J., Bannon, Y., Rogers, J. E., Milo, K. M., Stock, S. L., & Wilkinson, B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05305whi · Cited by 1,730 · see citing works
Video game training enhances cognitive control in older adults
Anguera, J. A., Boccanfuso, J., Rintoul, J. L., Al-Hashimi, O., Faraji, F., Janowich, J., Kong, E., Larraburo, Y., Rolle, C., Johnston, E., et al. (2013) · Nature · doi:10.1038/nature12486 · Cited by 1,666 · see citing works
Training and plasticity of working memory
Klingberg, T. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.05.002 · Cited by 1,585 · see citing works
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167 · see citing works
Top-down suppression deficit underlies working memory impairment in normal aging
Gazzaley, A., Cooney, J. W., Rissman, J., & D'Esposito, M. (2005) · Nature Neuroscience · doi:10.1038/nn1543 · Cited by 934 · see citing works
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder
Pelham, W. E., & Fabiano, G. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701818681 · Cited by 917 · see citing works
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications
Volkow, N. D., Wang, G.-J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., et al. (2009) · JAMA · doi:10.1001/jama.2009.1308 · Cited by 728 · see citing works
Self-citationKonrad, K., & Eickhoff, S. B. (2010) · Human Brain Mapping · doi:10.1002/hbm.21058 · Cited by 670 · see citing works
Cortese, S., Ferrin, M., Brandeis, D., Buitelaar, J., Daley, D., Dittmann, R. W., Holtmann, M., Santosh, P., Stevenson, J., Stringaris, A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.12.010 · Cited by 627 · see citing works
Rapport, M. D., Orban, S. A., Kofler, M. J., & Friedman, L. M. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.08.005 · Cited by 517 · see citing works
Toplak, M. E., Bucciarelli, S. M., Jain, U., & Tannock, R. (2008) · Child Neuropsychology · doi:10.1080/09297040802070929 · Cited by 401 · see citing works
Dovis, S., Van der Oord, S., Wiers, R. W., & Prins, P. J. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121651 · Cited by 272 · see citing works
Swanson, J., Baler, R. D., & Volkow, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.160 · Cited by 252 · see citing works
Pelham, W. E., Fabiano, G. A., Waxmonsky, J. G., Greiner, A. R., Gnagy, E. M., Pelham, W. E., Coxe, S., Verley, J., Bhatia, I., Hart, K., et al. (2016) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2015.1105138 · Cited by 251 · see citing works
PIETRZAK, R., MOLLICA, C., MARUFF, P., & SNYDER, P. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.10.002 · Cited by 214 · see citing works
Sikirica, V., Lü, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 206 · see citing works
Hardy, J. L., Nelson, R. A., Thomason, M. E., Sternberg, D. A., Katovich, K., Farzin, F., & Scanlon, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134467 · Cited by 183 · see citing works
Finding Optimal Cutpoints for Continuous Covariates with Binary and Time-to-Event Outcomes
Williams, B. A., Mandrekar, J. N., Mandrekar, S. J., Seiler, S., & Furth, A. F. (2006) · Cited by 173 · see citing works
The NIMH experimental medicine initiative
Insel, T. R. (2015) · World Psychiatry · doi:10.1002/wps.20227 · Cited by 165 · see citing works
Vaisman, N., Kaysar, N., Zaruk-Adasha, Y., Pelled, D., Brichon, G., Zwingelstein, G., & Bodennec, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1170 · Cited by 160 · see citing works
Pliszka, S. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-006-9017-3 · Cited by 158 · see citing works
Friedman, L. A., & Rapoport, J. L. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.11.007 · Cited by 154 · see citing works
van Dongen‐Boomsma, M., Vollebregt, M. A., Buitelaar, J. K., & Slaats‐Willemse, D. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12218 · Cited by 142 · see citing works
Why Do Children With ADHD Discontinue Their Medication?
Toomey, S. L., Sox, C. M., Rusinak, D., & Finkelstein, J. A. (2012) · Clinical Pediatrics · doi:10.1177/0009922812446744 · Cited by 118 · see citing works
Are There Executive Dysfunction Subtypes Within ADHD?
Roberts, B. A., Martel, M. M., & Nigg, J. T. (2017) · Journal of Attention Disorders · doi:10.1177/1087054713510349 · Cited by 116 · see citing works
Bavelier, D., & Davidson, R. J. (2013) · Nature · doi:10.1038/494425a · Cited by 100 · see citing works
Parenting Interventions for ADHD: A Systematic Literature Review and Meta-Analysis
Coates, J., Taylor, J. A., & Sayal, K. (2015) · Journal of Attention Disorders · doi:10.1177/1087054714535952 · Cited by 97 · see citing works
The role of treatment acceptability in the initiation of treatment for ADHD
Krain, A. L., Kendall, P. C., & Power, T. J. (2005) · Journal of Attention Disorders · doi:10.1177/1087054705279996 · Cited by 95 · see citing works
Chacko, A., Kofler, M., & Jarrett, M. (2014) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-014-0171-5 · Cited by 93 · see citing works
Gau, S. S.-F., & Shang, C.-Y. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990836 · Cited by 91 · see citing works
Schatz, N. K., Fabiano, G. A., Cunningham, C. E., dosReis, S., Waschbusch, D. A., Jerome, S., Lupas, K., & Morris, K. L. (2015) · The Patient - Patient-Centered Outcomes Research · doi:10.1007/s40271-015-0112-5 · Cited by 74 · see citing works
Johnston, C., Hommersen, P., & Seipp, C. (2008) · Behavior Therapy · doi:10.1016/j.beth.2007.04.002 · Cited by 72 · see citing works
Deficits in Cognitive Control, Timing and Reward Sensitivity Appear to be Dissociable in ADHD
de Zeeuw, P., Weusten, J., van Dijk, S., van Belle, J., & Durston, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051416 · Cited by 71 · see citing works
Rivero, T. S., Núñez, L., Pires, E. U., & Bueno, O. F. A. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00151 · Cited by 53 · see citing works
Faridi, N., Karama, S., Burgaleta, M., White, M. T., Evans, A. C., Fonov, V., Collins, D. L., & Waber, D. P. (2015) · Neuropsychology · doi:10.1037/neu0000079 · Cited by 42 · see citing works
O'Connor, B. C., Garner, A. A., Peugh, J. L., Simon, J., & Epstein, J. N. (2015) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000124 · Cited by 31 · see citing works
Abas, M. (1996) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199604)11:4 · Cited by 21 · see citing works
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
Hammerness, P., Fried, R., Petty, C., Meller, B., & Biederman, J. (2014) · Child Neuropsychology · doi:10.1080/09297049.2013.790359 · Cited by 14 · see citing works
Biederman, J., Chan, J., Spencer, T. J., Woodworth, K. Y., Kenworthy, T., Fried, R., Bhide, P., & Faraone, S. V. (2015) · Journal of Brain Sciences · doi:10.18488/journal.83/2015.1.2/83.2.43.53 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- CANTAB [Cognitive assessment software]. Cambridge Cognition; 2016.
Cited by
Sorted by citations
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517 · see citing works
Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30017-0 · Cited by 385 · see citing works
Self-citationIntroduction of digital therapeutics
Hong, J. S., Wasden, C. L., & Han, D. H. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106319 · Cited by 163 · see citing works
Peñuelas‐Calvo, I., Jiang-Lin, L. K., Serrano, B. G., Delgado‐Gómez, D., Navarro-Jimenez, R., Baca‐García, E., & Porras‐Segovia, A. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01557-w · Cited by 132 · see citing works
Nazarova, V. A., Sokolov, A. V., Chubarev, V. N., Tarasov, V. V., & Schiöth, H. B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1066988 · Cited by 111 · see citing works
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD
Kollins, S. H., Childress, A. C., Heusser, A. C., & Lutz, J. G. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00429-0 · Cited by 101 · see citing works
Self-citationVeloso, A. S., Vicente, S., & Filipe, M. G. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02983 · Cited by 86 · see citing works
Pandian, G. S. B., Jain, A., Raza, Q., & Sahu, K. K. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113742 · Cited by 66 · see citing works
Digital health interventions for youth with ADHD: A mapping review
Lakes, K. D., Cibrian, F. L., Schuck, S. E. B., Nelson, M. A., & Hayes, G. R. (2022) · Computers in Human Behavior Reports · doi:10.1016/j.chbr.2022.100174 · Cited by 62 · see citing works
Fitzgerald, K. D., Schroder, H. S., & Marsh, R. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.11.012 · Cited by 60 · see citing works
Extended reality for mental health: Current trends and future challenges
Pons, P., Medrano, S. N., & Soler-Dominguez, J. L. (2022) · Frontiers in Computer Science · doi:10.3389/fcomp.2022.1034307 · Cited by 59 · see citing works
Zhao, L., Agazzi, H. C., Du, Y., Meng, H., Maku, R., Li, K. Z., Aspinall, P. A., GARVAN, C. W., & Fang, S. (2024) · Journal of Medical Internet Research · doi:10.2196/55569 · Cited by 59 · see citing works
Medina, R., Bouhaben, J., de Ramón, I., Cuesta, P., Antón‐Toro, L. F., Pacios, J., Quintero, J., Ramos‐Quiroga, J. A., & Maestú, F. (2021) · Journal of Medical Internet Research · doi:10.2196/25466 · Cited by 57 · see citing works
Yerys, B. E., Bertollo, J. R., Kenworthy, L. E., Dawson, G., Marco, E. J., Schultz, R. T., & Sikich, L. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3856-7 · Cited by 57 · see citing works
He, F., Qi, Y., Zhou, Y., Cao, A., Yue, X., Fang, S., & Zheng, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1054831 · Cited by 45 · see citing works
Vacca, R. A., Augello, A., Gallo, L., Caggianese, G., Malizia, V., Grutta, S. L., Murero, M., Valenti, D., Tullo, A., Balech, B., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105156 · Cited by 44 · see citing works
Chacko, A., Merrill, B. M., Kofler, M. J., & Fabiano, G. A. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02890-3 · Cited by 56 · see citing works
Choi, E., Yoon, E.-H., & Park, M.-H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.986687 · Cited by 37 · see citing works
A Review of Working Memory Training in the Management of Attention Deficit Hyperactivity Disorder
Alsaad, M. S., Al-Jabri, B., & Almarzouki, A. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.686873 · Cited by 32 · see citing works
Integrated cognitive and physical fitness training enhances attention abilities in older adults
Anguera, J. A., Volponi, J. J., Simon, A. J., Gallen, C. L., Rolle, C. E., Anguera‐Singla, R., Pitsch, E. A., THOMPSON, C. J., & Gazzaley, A. H. (2022) · npj Aging · doi:10.1038/s41514-022-00093-y · Cited by 36 · see citing works
Robledo-Castro, C., Castillo, L., & Corchado, J. M. (2022) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-022-07292-5 · Cited by 34 · see citing works
Lucchese, B. D., Parravicini, S., Filogna, S., Mangani, G., Beani, E., Lieto, M., Bardoni, A., Bertamino, M., Papini, M., Tacchino, C. M., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1295273 · Cited by 33 · see citing works
Developing Serious Video Games to Treat Attention Deficit Hyperactivity Disorder: Tutorial Guide
Sújar, A., Martín-Moratinos, M., Rodrigo-Yanguas, M., Bella-Fernández, M., González, C., Delgado‐Gómez, D., & Blasco-Fontecilla, H. (2022) · JMIR Serious Games · doi:10.2196/33884 · Cited by 33 · see citing works
Bove, R. M., Rowles, W. M., Zhao, C., Anderson, A., Friedman, S., Langdon, D. W., Alexander, A. M., Sacco, S., Henry, R. G., Gazzaley, A. H., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520930371 · Cited by 31 · see citing works
Long-term maintenance of multitasking abilities following video game training in older adults
Anguera, J. A., Schachtner, J. N., Simon, A. J., Volponi, J. J., Javed, S., Gallen, C. L., & Gazzaley, A. H. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.02.023 · Cited by 29 · see citing works
Review and Implementation of Self-Help and Automated Tools in Mental Health Care
Chan, S. R., Li, L., Torous, J. B., Gratzer, D., & Yellowlees, P. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.07.001 · Cited by 30 · see citing works
Jiang, X., Chen, Y., Huang, W., Zhang, T., Gao, C., Xing, Y., & Zheng, Y. (2020) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3313831.3376374 · Cited by 29 · see citing works
Patients' perspective on digital technologies in advanced genitourinary cancers
Rodler, S., Buchner, A., Stief, C. G., Heinemann, V., Staehler, M., & Casuscelli, J. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2020.03.018 · Cited by 27 · see citing works
Neri, F., Smeralda, C. L., Momi, D., Sprugnoli, G., Menardi, A., Ferrone, S., Rossi, S., Rossi, A., Di Lorenzo, G., & Santarnecchi, E. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.598410 · Cited by 27 · see citing works
Assessing Cognitive Function in Multiple Sclerosis With Digital Tools: Observational Study
Hsu, W., Rowles, W. M., Anguera, J. A., Anderson, A., Younger, J. W., Friedman, S., Gazzaley, A. H., & Bove, R. M. (2021) · Journal of Medical Internet Research · doi:10.2196/25748 · Cited by 27 · see citing works
Hsu, W., Rowles, W. M., Anguera, J. A., Zhao, C., Anderson, A., Alexander, A. M., Sacco, S., Henry, R. G., Gazzaley, A. H., & Bove, R. M. (2021) · Journal of Medical Internet Research · doi:10.2196/24356 · Cited by 26 · see citing works
Adjuvant Therapy for Attention in Children with ADHD Using Game-Type Digital Therapy
Kim, S.-C., Lee, H., Lee, H.-S., Kim, G., & Song, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192214982 · Cited by 24 · see citing works
Assessing Cognition Outside of the Clinic
Hays, R., Henson, P., Wisniewski, H., Hendel, V., Vaidyam, A. N., & Torous, J. B. (2019) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2019.08.003 · Cited by 22 · see citing works
Lee, H., Lee, S., Hwang, M., & Woo, K. (2025) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02788-5 · Cited by 21 · see citing works
Engelhard, M., & Kollins, S. H. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1077-1 · Cited by 20 · see citing works
Self-citationYoung, J. R., Yanagihara, A., Dew, R., & Kollins, S. (2021) · CNS Drugs · doi:10.1007/s40263-021-00806-z · Cited by 13 · see citing works
Self-citationHa, S., Han, J. H., Ahn, J., Lee, K., Heo, J., Choi, Y., Park, J. Y., & Cheon, K.-A. A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.018 · Cited by 19 · see citing works
Do-It-Yourself Gamified Cognitive Training: Viewpoint
van de Weijer, S. C. F., Kuijf, M. L., de Vries, N. M., Bloem, B. R., & Duits, A. (2019) · JMIR Serious Games · doi:10.2196/12130 · Cited by 19 · see citing works
Lawrence‐Sidebottom, D., Huffman, L. G., Huberty, J., Beatty, C. C., Roots, M., Roots, K., Parikh, A., Guerra, R., & Weiser, J. (2023) · JMIR Formative Research · doi:10.2196/46578 · Cited by 20 · see citing works
Baweja, R. K., Faraone, S. V., Childress, A. C., Weiss, M. D., Loo, S. K., Wilens, T. E., & Waxmonsky, J. G. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0022 · Cited by 17 · see citing works
Sustained benefits of cognitive training in children with inattention, three-year follow-up
Jurigova, B. G., Gerdes, M. R., Anguera, J. A., & Marco, E. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246449 · Cited by 15 · see citing works
Robledo-Castro, C., Castaño, P. R. L., & Bonilla-Santos, G. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231187164 · Cited by 20 · see citing works
Understanding ADHD: Toward an Innovative Therapeutic Intervention
Camp, A., Pastrano, A., Gómez, V., Stephenson, K., Delatte, W., Perez, B., Syas, H., & Guiseppi‐Elie, A. (2021) · Bioengineering · doi:10.3390/bioengineering8050056 · Cited by 15 · see citing works
Interdisciplinary Tensions When Developing Digital Interventions Supporting Individuals With ADHD
Cibrian, F. L., Monteiro, E. M., Schuck, S. E. B., Nelson, M. A., Hayes, G. R., & Lakes, K. D. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.876039 · Cited by 15 · see citing works
Precision gaming for health: Computer games as digital medicine
Kinross, J. K. (2018) · Methods · doi:10.1016/j.ymeth.2018.09.009 · Cited by 15 · see citing works
Enhancing attention in children using an integrated cognitive-physical videogame: A pilot study
Anguera, J. A., Rowe, M. A., Volponi, J. J., Elkurdi, M., Jurigova, B. G., Simon, A. J., Anguera‐Singla, R., Gallen, C. L., Gazzaley, A. H., & Marco, E. J. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00812-z · Cited by 13 · see citing works
Sun, T. H., Yeom, J. W., Choi, K., Kim, J. L., Lee, H., Kim, H. J., & Cho, C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1169030 · Cited by 14 · see citing works
Caselles‐Pina, L., Sújar, A., Quesada‐López, A., & Delgado‐Gómez, D. (2023) · Brain and Behavior · doi:10.1002/brb3.3265 · Cited by 11 · see citing works
Choi, H., Kim, B., Kim, I., Kang, J.-G., Lee, Y., Lee, H. K., & Park, M.-H. (2023) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.230044 · Cited by 12 · see citing works
Digitale Innovation in der Medizin – die COVID-19-Pandemie als Akzelerator von „digital health“
Mumm, J., Rodler, S., Mumm, M.-L., Bauer, R. M., & Stief, C. G. (2020) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-39083 · Cited by 12 · see citing works
A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial
Victoria, L. W., Oberlin, L. E., Ilieva, I. P., Jaywant, A., Kanellopoulos, D., Mercaldi, C. J., Stamatis, C. A., Farlow, D., Kollins, S. H., Tisor, O., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01995-z · Cited by 11 · see citing works
Self-citationDigitale Innovation in der Medizin – die COVID-19-Pandemie als Akzelerator von „digital health“
Mumm, J.-N., Rodler, S., Mumm, M.-L., Bauer, R. M., & Stief, C. G. (2020) · Journal für Urologie und Urogynäkologie/Österreich · doi:10.1007/s41972-020-00126-2 · Cited by 11 · see citing works
Kozora, E., Zell, J., Baraghoshi, D., Smith, R. M., & Strand, M. J. (2022) · Lupus · doi:10.1177/09612033221098534 · Cited by 11 · see citing works
Ayearst, L. E., Brancaccio, R., & Weiss, M. D. (2023) · Journal of Pediatric Neuropsychology · doi:10.1007/s40817-023-00152-6 · Cited by 9 · see citing works
Murray, A. L., Thye, M. D., Obsuth, I., Cai, S., Lui, M., Orr, C., & Saravanan, A. (2024) · JMIR Mental Health · doi:10.2196/56066 · Cited by 11 · see citing works
Object Recognition Memory Deficits in ADHD: A Meta-analysis
Lobato-Camacho, F. J., & Faísca, L. (2024) · Neuropsychology Review · doi:10.1007/s11065-024-09645-3 · Cited by 8 · see citing works
Digital Medicine – The New Frontier for AI in Healthcare
Ho, D., & Teo, G. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000015 · Cited by 8 · see citing works
Giannaraki, M., Moumoutzis, N., Papatzanis, Y., Κουρκούτας, Η., & Mania, K. (2021) · IEEE Global Engineering Education Conference (EDUCON) · doi:10.1109/educon46332.2021.9453999 · Cited by 8 · see citing works
Ono, T., Sakurai, T., Kasuno, S., & Murai, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-15679-5 · Cited by 8 · see citing works
Giannaraki, M., Moumoutzis, N., Κουρκούτας, Η., & Mania, K. (2020) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-49932-7_55 · Cited by 8 · see citing works
de Ramón, I., Pacios, J., Medina, R., Bouhaben, J., Cuesta, P., Antón‐Toro, L. F., Quintero, J., Ramos‐Quiroga, J. A., & Maestú, F. (2022) · Brain Communications · doi:10.1093/braincomms/fcac038 · Cited by 7 · see citing works
Xueke, W., & Tingyong, F. (2023) · Advances in Psychological Science · doi:10.3724/sp.j.1042.2023.02106 · Cited by 7 · see citing works
Mikami, K., Miyajima, T., Nishino, R., Kawazoe, N., Kinoshita, Y., Okada, T., & Fukuju, H. (2025) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13833 · Cited by 6 · see citing works
Bao, M., Feng, S., Wang, J., Ye, J., Wang, J., Li, W., Jiang, K., & Yao, L. (2026) · JMIR Serious Games · doi:10.2196/76114 · Cited by 6 · see citing works
Kim, S.-C., & Lee, H. (2025) · Applied Sciences · doi:10.3390/app15020788 · Cited by 5 · see citing works
A systematic review and content analysis of serious video games for children with ADHD
Schultz, B. K., Evans, S. W., Carter, K. M., Dembowski, A., Lojinger, K., Murray, E. R., & Walcott, C. M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1605744 · Cited by 5 · see citing works
Research outside the laboratory: Longitudinal at-home neurostimulation
Jones, K. T., Smith, C. C., Gazzaley, A. H., & Zanto, T. P. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113894 · Cited by 5 · see citing works
Jung, M., Woo, J., Kim, S. J., Lim, Y. B., Kim, Y., Kang, D., Min, J., & Kim, B.-N. (2025) · JMIR Human Factors · doi:10.2196/70479 · Cited by 4 · see citing works
The Role of Serious Games in Healthcare and Its Contribution to the Healthcare Ecosystem
Bojan, K., Christogianni, A., & Mukaetova-Ladinska, E. B. (2022) · Advances in human and social aspects of technology book series · doi:10.4018/978-1-7998-9732-3.ch007 · Cited by 4 · see citing works
Mikami, K., Miyajima, T., Nishino, R., Kawazoe, N., Ochiai, T., Okada, T., & Fukuju, H. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70089 · Cited by 3 · see citing works
Role of Biomarkers in Personalized Medicine
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-5759-7_10 · Cited by 4 · see citing works
Wang, J., Bao, M., Li, W., Wang, J., Jiang, K., Yao, L., & Wang, Y. (2022) · Communications in computer and information science · doi:10.1007/978-981-19-8222-4_18 · Cited by 2 · see citing works
Trinczer, I. L., & Shalev, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237239 · Cited by 2 · see citing works
Liu, J. W., Jasim, M., Song, J., Ha, S.-H., Kim, J.-S., Kim, D., Lee, H., Kim, B. S., & Jung, H.-T. (2025) · ACM Transactions on Computer-Human Interaction · doi:10.1145/3772068 · Cited by 2 · see citing works
Vicarious value learning by differential outcomes training: A social transfer of control methodology
Lowe, R. J., Rittmo, J. Ö., Carlsson, R., & Gander, P. (2021) · MethodsX · doi:10.1016/j.mex.2021.101294 · Cited by 2 · see citing works
A therapy game for elementary students with ADHD
Bahana, R., Abdurachman, E., Gaol, F. L., Wiguna, T., Hutagalung, F. D., Dirgantoro, B. P., & Nugroho, E. (2023) · AIP conference proceedings · doi:10.1063/5.0114939 · Cited by 2 · see citing works
Improving Patient Care With Telemedicine Technology
Chen, E. T. (2019) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-7998-0047-7.ch001 · Cited by 2 · see citing works
Improving Patient Care With Telemedicine Technology
Chen, E. T. (2021) · IGI Global eBooks · doi:10.4018/978-1-7998-8052-3.ch008 · Cited by 2 · see citing works
Pugatch, M., Blum, N. J., Barbaresi, W. J., Rowe, J., Berna, M. S., Hennigan, S., Giovanelli, A., Penilla, C., Tebb, K., Mott, M., et al. (2024) · Frontiers in Education · doi:10.3389/feduc.2023.1183994 · Cited by 1 · see citing works
Choudari, K., Singh, S., Sreelekshmi, R., & Somvanshi, P. R. (2025) · Intelligent Medicine · doi:10.1016/j.imed.2025.12.004 · Cited by 1 · see citing works
Shah, S. M., Alhudaithi, G. S., & Alharbi, F. S. (2026) · BMC Psychology · doi:10.1186/s40359-026-04637-9 · Cited by 1 · see citing works
Cruz, S. G. R., Parga, M. L. B., Ruiz, J. E. C., Contreras-Cifuentes, A. T., Corredor, M. F. G., Cárdenas, J. M., Valdés, A. L. M., Amaya, V. V. P., Fajardo, L. A. M. P., & Orjuela, M. F. Z. (2020) · Enfoques · doi:10.24267/23898798.290 · Cited by 1 · see citing works
Kim, S.-C. (2024) · Applied Sciences · doi:10.3390/app14093792 · Cited by 1 · see citing works
Innovative Approaches to Addressing Pediatric Mental Health
Maslow, G., Chung, R. J., Heilbron, N., & Walter, B. K. (2024) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2024.07.019 · Cited by 1 · see citing works
Coding4Therapy: Enhancing Cognitive and Socio-emotional Skills in Children with ADHD
Toto, B., & Joyner, D. A. (2024) · ACM Virtual Global Computing Education Conference (SIGCSE Virtual) · doi:10.1145/3649165.3690124 · Cited by 1 · see citing works
Integrated cognitive and physical fitness training enhances attention abilities in older adultsPreprint
Anguera, J. A., Volponi, J. J., Simon, A. J., Gallen, C. L., Rolle, C. E., Anguera‐Singla, R., THOMPSON, C. J., & Gazzaley, A. H. (2021) · Research Square · doi:10.21203/rs.3.rs-1171873/v1 · Cited by 1 · see citing works
Bidopia, T., Engelhard, M., Kollins, S. H., & Lunsford‐Avery, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818872-9.00126-6 · Cited by 1 · see citing works
Self-citationFeng, S., Bao, M., Wang, J., Ye, J., Wang, J., Li, W., Jiang, K., & Yao, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4303654/v1 · Cited by 1 · see citing works
Digital technology-enabled home health care
van de Weijer, S. C. F. (2021) · doi:10.26481/dis.20210901sw
A Novel Digital Tool to Improve Attention of Children with Adhd: A Randomized Controlled TrialPreprint
Papanastasiou, G., Skianis, C. A., Drigas, A. S., & Soulis, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4183317
La thérapie digitale EndeavorRx auprès des enfants atteints de TDA/H : une étude de portée
GUIGNARD, L., Gelineau, A., & Mandigout, S. (2024) · Revue scientifiques des travaux de fin d'étude en rééducation et réadaptation. · doi:10.25965/rse2r.264
(2024) · Revue scientifiques des travaux de fin d'étude en rééducation et réadaptation. · doi:10.25965/rse2r.259
Organ-specific autoimmune disorders
Chatterjee, S., Yadav, M., Sharma, H., Jha, B., Neelam, D. K., Thakre, V., Pathak, H., Devki, & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18776-6.00003-7
Jo, U., Kim, S., Jeong, Y. J., Jun, S. J., Park, J.-Y., Kim, S.-C., Hoe, H., & Song, J.-H. (2025) · doi:10.2196/preprints.75367
Neurochemical Mechanisms of Addiction
Nemets, V. V., Grinevich, V. P., & Gainetdinov, R. R. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700394
Stimulation of Casual Video Games on Spatial Memory and Pattern Separation in Children with ADHDPreprint
Lobato-Camacho, F. J., Carlos, L. J., & Pedro, V. J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5383939
Rivas-García, M., Vidal-Ramírez, C., Mora‐Traverso, M., Toledano-González, A., Rodríguez-Martínez, M. D. C., Molina-Torres, E., Marín-Marín, J.-A., Triviño-Juárez, J. M., Gea, M., & Ayuso, D. M. R. (2026) · Disability and Rehabilitation Assistive Technology · doi:10.1080/17483107.2026.2648864
- Authors
- Davis, N. O., Bower, J., & Kollins, S. H.
- Affiliations
- Duke University (US)
- Corresponding author
- Davis, Naomi O.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-01-11
- Volume
- 13
- Issue
- 1
- Pages
- e0189749
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5764249
- OpenAlex
- W2782909961
- Cited by
- 106
- References
- 44
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 16 · 2023: 12 · 2022: 19 · 2021: 18 · 2020: 13 · 2019: 5 · 2018: 2
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Akili Interactive Labs
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- children with ADHD, digital interventions, home treatment, cognitive training, attention, spatial working memory, inhibition, treatment acceptability, neurocognitive impairment, children
- MeSH terms
- Attention, Attention Deficit Disorder with Hyperactivity, Child, Cognition, Female, Humans, Male, Memory, Short-Term, United States, Case-Control Studies, Executive Function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review